{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:19Z","timestamp":1780984759109,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Kunming Health Science and Technology Talent Project - 10 Projects of China","award":["2023-SW (GUIDE)-07"],"award-info":[{"award-number":["2023-SW (GUIDE)-07"]}]},{"name":"Spring City Famous Medical Special Project","award":["N08901329"],"award-info":[{"award-number":["N08901329"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08092-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:04:20Z","timestamp":1775664260000},"page":"3441-3458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sj\u00f6gren\u2019s syndrome to total risk non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"45","author":[{"given":"Hongye","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqian","family":"Zhouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-4732","authenticated-orcid":false,"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"3","key":"8092_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y et al (2024) Epidemiology of Sj\u00f6gren syndrome. NAT REV RHEUMATOL 20(3):158\u2013169. https:\/\/doi.org\/10.1038\/s41584-023-01057-6","journal-title":"NAT REV RHEUMATOL"},{"issue":"8","key":"8092_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, La Rocca G, Ferro F (2024) Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(8):473\u2013491. https:\/\/doi.org\/10.1038\/s41584-024-01135-3","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"8092_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103738","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lin Q, Cheng H et al (2025) Immunometabolic shifts in autoimmune disease: mechanisms and pathophysiological implications. Autoimmun Rev 24(3):103738. https:\/\/doi.org\/10.1016\/j.autrev.2024.103738","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8092_CR4","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1007\/s10067-025-07489-7","volume":"44","author":"G Jonu\u0161ien\u0117","year":"2025","unstructured":"Jonu\u0161ien\u0117 G, Ka\u010d\u0117nien\u0117 A, Gedvilait\u0117 V et al (2025) Cancer risk in patients with Sj\u00f6gren\u2019s syndrome in Lithuanian cohort study. Clin Rheumatol 44(7):2883\u20132887. https:\/\/doi.org\/10.1007\/s10067-025-07489-7","journal-title":"Clin Rheumatol"},{"issue":"Supple 1","key":"8092_CR5","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1182\/blood-2024-204266","volume":"144","author":"M Labrano Elias","year":"2024","unstructured":"Labrano Elias M, Von Glasenapp S, Chiattone C et al (2024) Uncovering the epidemiology, therapy patterns and outcomes of MALT lymphoma in Latin America: a multinational retrospective cohort study. Blood 144(Supple 1):3718\u20133718. https:\/\/doi.org\/10.1182\/blood-2024-204266","journal-title":"Blood"},{"issue":"7","key":"8092_CR6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10067-024-06993-6","volume":"43","author":"N Ansari","year":"2024","unstructured":"Ansari N, Salesi M (2024) The association between primary Sjogren\u2019s syndrome and non-Hodgkin\u2019s lymphoma: a systematic review and meta-analysis of cohort studies. Clin Rheumatol 43(7):2177\u20132186. https:\/\/doi.org\/10.1007\/s10067-024-06993-6","journal-title":"Clin Rheumatol"},{"issue":"8","key":"8092_CR7","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1093\/rheumatology\/kez052","volume":"60","author":"G Nocturne","year":"2021","unstructured":"Nocturne G, Pontarini E, Bombardieri M, Mariette X (2021) Lymphomas complicating primary Sj\u00f6gren\u2019s syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford) 60(8):3513\u20133521. https:\/\/doi.org\/10.1093\/rheumatology\/kez052","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8092_CR8","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/rheumatology\/keab939","volume":"61","author":"LG Chatzis","year":"2022","unstructured":"Chatzis LG, Stergiou IE, Goules AV et al (2022) Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981-2021). Rheumatology 61(9):3576\u20133585. https:\/\/doi.org\/10.1093\/rheumatology\/keab939","journal-title":"Rheumatology"},{"issue":"5","key":"8092_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103084","volume":"21","author":"H Zhong","year":"2022","unstructured":"Zhong H, Liu S, Wang Y et al (2022) Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis. Autoimmun Rev 21(5):103084. https:\/\/doi.org\/10.1016\/j.autrev.2022.103084","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8092_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05935-y","volume":"45","author":"O Rusinovich-Lovgach","year":"2025","unstructured":"Rusinovich-Lovgach O, Plaza Z, Fern\u00e1ndez-Castro M et al (2025) High incidence of lymphoma in Sj\u00f6gren\u2019s disease: predictors and mortality implications in a prospective cohort study. Rheumatol Int 45(8):184. https:\/\/doi.org\/10.1007\/s00296-025-05935-y","journal-title":"Rheumatol Int"},{"issue":"12","key":"8092_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1102","volume":"11","author":"H Zhu","year":"2023","unstructured":"Zhu H, Zheng J, Zhou Y et al (2023) PRMT5 participates in B cell overactivation in patients with primary Sjogren\u2019s syndrome (pSS) through RSAD2-mediated NF-\u03baB signaling. Immun Inflamm Dis 11(12):e1102. https:\/\/doi.org\/10.1002\/iid3.1102","journal-title":"Immun Inflamm Dis"},{"key":"8092_CR12","doi-asserted-by":"publisher","unstructured":"Boni, A, Nicolai, R, Caiello, I, Marinaro, et al. Hyperactivation and altered selection of B cells in patients with paediatric Sjogren\u2019s syndrome. RMD Open. 2024;10(1).\u00a0https:\/\/doi.org\/10.1136\/rmdopen-2023-003800.\u00a0","DOI":"10.1136\/rmdopen-2023-003800"},{"key":"8092_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040936","author":"M Sousa-Pimenta","year":"2023","unstructured":"Sousa-Pimenta M, Estevinho MM, Sousa Dias M, Martins \u00c2, Estevinho LM (2023) Oxidative stress and inflammation in B-cell lymphomas. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12040936","journal-title":"Antioxidants"},{"key":"8092_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells7110189","author":"R Kennedy","year":"2018","unstructured":"Kennedy R, Klein U (2018) Aberrant activation of NF-\u03baB signalling in aggressive lymphoid malignancies. Cells. https:\/\/doi.org\/10.3390\/cells7110189","journal-title":"Cells"},{"key":"8092_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106939","volume":"88","author":"L Li","year":"2020","unstructured":"Li L, Yu R, Cai T et al (2020) Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol 88:106939. https:\/\/doi.org\/10.1016\/j.intimp.2020.106939","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"8092_CR16","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/acr.25400","volume":"76","author":"K Nguyen","year":"2024","unstructured":"Nguyen K, Mitchell BD (2024) A guide to understanding mendelian randomization studies. Arthritis Care Res 76(11):1451\u20131460. https:\/\/doi.org\/10.1002\/acr.25400","journal-title":"Arthritis Care Res"},{"issue":"11","key":"8092_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jbmr\/zjae136","volume":"39","author":"CE Lovegrove","year":"2024","unstructured":"Lovegrove CE, Howles SA, Furniss D, Holmes MV (2024) Causal inference in health and disease: a review of the principles and applications of Mendelian randomization. J Bone Miner Res 39(11):1539\u20131552. https:\/\/doi.org\/10.1093\/jbmr\/zjae136","journal-title":"J Bone Miner Res"},{"issue":"11","key":"8092_CR18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco M F, Pattaro C, K\u00f6ttgen A (2016) Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 27(11):3253\u20133265. https:\/\/doi.org\/10.1681\/ASN.2016010098","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"8092_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41588-023-01648-9","volume":"56","author":"S Zhao","year":"2024","unstructured":"Zhao S, Crouse W, Qian S, Luo K, Stephens M, He X (2024) Adjusting for genetic confounders in transcriptome-wide association studies improves discovery of risk genes of complex traits. Nat Genet 56(2):336\u2013347. https:\/\/doi.org\/10.1038\/s41588-023-01648-9","journal-title":"Nat Genet"},{"issue":"7944","key":"8092_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8","journal-title":"Nature"},{"issue":"6","key":"8092_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases 61(6):554\u20138. https:\/\/doi.org\/10.1136\/ard.61.6.554","journal-title":"Annals of the Rheumatic Diseases"},{"key":"8092_CR22","doi-asserted-by":"publisher","unstructured":"Shiboski, CH, Shiboski, SC, Seror, R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571.\u00a0","DOI":"10.1136\/annrheumdis-2016-210571"},{"issue":"9","key":"8092_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N et al (2023) Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol 24(9):1540\u20131551. https:\/\/doi.org\/10.1038\/s41590-023-01588-w","journal-title":"Nat Immunol"},{"issue":"11","key":"8092_CR24","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J (2021) A generalized linear mixed model association tool for biobank-scale data. Nat Genet 53(11):1616\u20131621. https:\/\/doi.org\/10.1038\/s41588-021-00954-4","journal-title":"Nat Genet"},{"issue":"16","key":"8092_CR25","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326(16):1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"issue":"2","key":"8092_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jtcvs.2020.09.134","volume":"163","author":"M Baiocchi","year":"2022","unstructured":"Baiocchi M, Woo YJ, Chiu P, Goldstone AB (2022) The role and significance of sensitivity analyses in enhancing the statistical validity of clinical studies. J THORAC CARDIOV SUR 163(2):749\u2013753. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.09.134","journal-title":"J THORAC CARDIOV SUR"},{"issue":"5","key":"8092_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"8092_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"8092_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-023-00823-3","author":"M Aslam","year":"2023","unstructured":"Aslam M (2023) Cochran\u2019s Q test for analyzing categorical data under uncertainty. J Big Data. https:\/\/doi.org\/10.1186\/s40537-023-00823-3","journal-title":"J Big Data"},{"issue":"11","key":"8092_CR30","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco M F, Minelli C et al (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36(11):1783\u20131802. https:\/\/doi.org\/10.1002\/sim.7221","journal-title":"Stat Med"},{"issue":"11","key":"8092_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin Z, Deng Y, Pan W (2021) Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet 17(11):e1009922. https:\/\/doi.org\/10.1371\/journal.pgen.1009922","journal-title":"PLoS Genet"},{"key":"8092_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife. https:\/\/doi.org\/10.7554\/eLife.34408","journal-title":"Elife"},{"issue":"5","key":"8092_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"8092_CR34","doi-asserted-by":"publisher","unstructured":"Valero-Mora, P. ggplot2:Elegant Graphics for Data Analysis J Stat Softw. 2010\u201301\u201301; 35 (Book Review 1): https:\/\/doi.org\/10.18637\/jss.v035.b01.","DOI":"10.18637\/jss.v035.b01"},{"issue":"3","key":"8092_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10555-024-10184-9","volume":"43","author":"B Thapa","year":"2024","unstructured":"Thapa B, Kato S, Nishizaki D et al (2024) OX40\/OX40 ligand and its role in precision immune oncology. Cancer Metast Rev 43(3):1001\u20131013. https:\/\/doi.org\/10.1007\/s10555-024-10184-9","journal-title":"Cancer Metast Rev"},{"issue":"15","key":"8092_CR36","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","volume":"187","author":"F Andreata","year":"2024","unstructured":"Andreata F, Laura C, Rav\u00e0 M et al (2024) Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell 187(15):4078-4094.e21. https:\/\/doi.org\/10.1016\/j.cell.2024.05.038","journal-title":"Cell"},{"key":"8092_CR37","doi-asserted-by":"publisher","unstructured":"Rojas-Diaz, JM, Solorzano-Ibarra, F, Garcia-Barrientos, et al. Uncovering the expression pattern of the costimulatory receptors ICOS, 4\u20131BB, and OX-40 in exhausted peripheral and tumor-infiltrating natural killer cells from patients with cervical cancer. Int J Mol Sci. 2024;25(16).\u00a0https:\/\/doi.org\/10.3390\/ijms25168775.\u00a0","DOI":"10.3390\/ijms25168775"},{"issue":"1","key":"8092_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02105-7","volume":"10","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Wang JB, Sun R et al (2025) Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma. Signal Transduct Target Ther 10(1):29. https:\/\/doi.org\/10.1038\/s41392-024-02105-7","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"8092_CR39","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00262-023-03474-8","volume":"72","author":"C Battin","year":"2023","unstructured":"Battin C, De Sousa Linhares A, Leitner J et al (2023) Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. Cancer Immunol Immunother 72(9):3029\u20133043. https:\/\/doi.org\/10.1007\/s00262-023-03474-8","journal-title":"Cancer Immunol Immunother"},{"key":"8092_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217287","volume":"605","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang J, Lin R et al (2024) Pirfenidone antagonizes TGF-\u03b21-mediated gabapentin resistance via reversal of desmoplasia and the \u201ccold\u201d microenvironment in pancreatic cancer. Cancer Lett 605:217287. https:\/\/doi.org\/10.1016\/j.canlet.2024.217287","journal-title":"Cancer Lett"},{"key":"8092_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1228486","volume":"14","author":"S Salek-Ardakani","year":"2023","unstructured":"Salek-Ardakani S, Zajonc DM, Croft M (2023) Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications. Front Immunol 14:1228486. https:\/\/doi.org\/10.3389\/fimmu.2023.1228486","journal-title":"Front Immunol"},{"issue":"6","key":"8092_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM et al (2015) 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med 21(6):581\u2013590. https:\/\/doi.org\/10.1038\/nm.3838","journal-title":"Nat Med"},{"issue":"13_Supple","key":"8092_CR43","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1158\/1538-7445.am2017-3746","volume":"77","author":"D Schneider","year":"2017","unstructured":"Schneider D, Xiong Y, Wu D, Dropulic B, Orentas R (2017) Abstract 3746: Plasma membrane spanning and linker-domains from tumor necrosis factor receptor superfamily (TNFRSF) proteins provide novel functionality to chimeric antigen receptors (CARs) expressed in human T cells. Cancer Research 77(13_Supple):3746\u20133746. https:\/\/doi.org\/10.1158\/1538-7445.am2017-3746","journal-title":"Cancer Research"},{"key":"8092_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1605221","volume":"16","author":"P Zhao","year":"2025","unstructured":"Zhao P, Chen K, Yang L et al (2025) Clinical and functional characterization of a novel TNFRSF9 variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis. Front Immunol 16:1605221. https:\/\/doi.org\/10.3389\/fimmu.2025.1605221","journal-title":"Front Immunol"},{"issue":"18","key":"8092_CR45","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/blood.2019000644","volume":"134","author":"I Somekh","year":"2019","unstructured":"Somekh I, Thian M, Medgyesi D et al (2019) CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis. Blood 134(18):1510\u20131516. https:\/\/doi.org\/10.1182\/blood.2019000644","journal-title":"Blood"},{"issue":"5","key":"8092_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.autrev.2012.10.006","volume":"12","author":"Y Yao","year":"2013","unstructured":"Yao Y, Liu Z, Jallal B, Shen N, R\u00f6nnblom L (2013) Type I interferons in Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 12(5):558\u2013566. https:\/\/doi.org\/10.1016\/j.autrev.2012.10.006","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8092_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","volume":"32","author":"GE Katsifis","year":"2007","unstructured":"Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T lymphocytes in Sj\u00f6gren\u2019s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32(3):252\u2013264. https:\/\/doi.org\/10.1007\/s12016-007-8011-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl 3","key":"8092_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000733","volume":"4","author":"I Etxeberria","year":"2020","unstructured":"Etxeberria I, Glez-Vaz J, Teijeira \u00c1, Melero I (2020) New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis. ESMO Open 4(Suppl 3):e000733. https:\/\/doi.org\/10.1136\/esmoopen-2020-000733","journal-title":"ESMO Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08092-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08092-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08092-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:06Z","timestamp":1780982706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08092-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8092"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08092-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study utilized publicly available summary-level data from previously published genome-wide association studies. No individual-level data were used. Therefore, ethical approval and informed consent were not required for this analysis, as confirmed by our institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}